Aptus Pharma

APPL
Price
-- --
 
Micro Cap
₹480 Cr.
Aptus Pharma operates as a marketing and distribution company for finished pharmaceutical products. It utilizes a contract manufacturing model to offer a wide array of medications across various ther… More
Aptus Pharma operates as a marketing and distribution company for finished pharmaceutical products. It utilizes a contract manufacturing model to offer a wide array of medications across various therapeutic areas, including anti-infectives, gastrointestinal treatments, antacids, and products for anti-allergic and respiratory needs. Less
Aptus Pharma operates as a marketing and distribution company for finished pharmaceutical products.… More
Aptus Pharma operates as a marketing and distribution company for finished pharmaceutical products. It utilizes a contract manufacturing model to offer a wide array of medications across various therapeutic areas, including anti-infectives, gastrointestinal treatments, antacids, and products for anti-allergic and respiratory needs. Less
Low
32.32
52W Range
High
310
PE
103.87
Sector PE
29.61
P/B
--
Div.Yield
--
ROE
44.5%
EBIDTA
--
ROCE
47.76
EPS
--
WhatsApp

Get instant stock alerts
  • Share Price
  • Financials
  • Revenue mix
  • Shareholdings
  • Peers
  • Forensics
Niche index constructed using market cap and revenue exposure of companies in this sector

Coming soon

  • 5D
  • 1M
  • 6M
  • YTD
  • 1Y
  • 5Y
  • MAX

  • Summary

  • Profit & Loss

  • Balance sheet

  • Cashflow

Yearly | Quarterly
View Detailed Summary View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly
(In Cr.)
(In Cr.)

This data is currently unavailable for this company.
Financial Ratio's
(In %)
Detailed P&L Report Detailed P&L Report
(In Cr.)
Detailed Balance Sheet
Financial Year (In Cr.)
Detailed Cash Flow

  • Product wise

  • Location wise

APPL
Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    APPL
    Revenue Mix
    Latest
    |
    Historic

    This data is currently unavailable for this company.

    More Info

    Shareholdings

    Holders
    Detailed Shareholdings

    This data is currently unavailable for this company.

    Peers
    Detailed Peers

    Forensics

    View Detailed Forensics

    Recent events

    • News

    • Corporate Actions

    Preferential Issue Approval
    Aug 08, 2026
    Fund Raising Approval
    Jun 12, 2026
    Aptus Pharma Ltd Approves Bonus Issue In 3:2 Ratio
    Mar 26, 2026
    Aptus Pharma Recommends Issue Of Bonus Equity Shares In Ratio Of 3:2
    Mar 24, 2026
    Aptus Pharma To Consider Bonus Shares
    Mar 17, 2026
    Aptus Pharma Expands Into Life-Saving Injectables And ICU Care
    Feb 26, 2026
    Events:
    Bonus
    3 bonus shares for every 2 held. Bonus shares should be credited within 3 days after the ex-date.
    Ex Date
    May 12, 2026
    Announcement Date
    Apr 27, 2026
    Announcement Date
    Nov 10, 2025

    More Micro Cap Ideas

    See similar 'Micro' cap companies with recent activity

    Promoter Buying

    Companies where the promoters are bullish

    Detailed List

    Capex

    Companies investing on expansion

    Detailed List

    Superstar Investor

    Companies where well known investors have invested

    Detailed List